US LNG exports surge but will buyers in China turn up?
CHICAGO - GE HealthCare (NASDAQ:GEHC), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $33.6 billion, has released its first combined software solution integrating its proprietary features and algorithms with MIM Encore, the company announced in a press release statement. According to InvestingPro data, the company maintains a strong financial health rating and generates annual revenues of $19.8 billion.
The integration aims to enhance digital imaging and workflow solutions across oncology, cardiology, and neurology departments. The combined platform is designed to improve diagnostic confidence and streamline workflows for healthcare providers using GE HealthCare systems alongside MIM software. With a healthy gross profit margin of 42%, the company demonstrates strong operational efficiency in its healthcare technology initiatives.
According to the company, the updated MIM Encore now includes dedicated post-processing tools for GE HealthCare systems, providing automated read preparation, structured reporting, and interpretation tools for PET/CT, SPECT/CT, and multi-modality fusion in a single platform.
In oncology, the software simplifies SPECT image processing with features including resolution recovery and attenuation correction. For cardiology, it offers advanced PET and SPECT tools with motion correction and automated quality checks. The neurology applications include reconstruction workflows with 3D rendering capabilities.
Jean-Luc Procaccini, President & CEO of Molecular Imaging & Computed Tomography at GE HealthCare, said the company aims to "provide tools that can help enhance providers’ confidence in decision making and support patients in receiving personalized care."
The software integration follows GE HealthCare’s acquisition of MIM Software in 2024. The company stated that the combined solution helps reduce manual entries and streamlines communication between clinicians.
GE HealthCare will showcase the MIM Encore platform at the SNMMI show in New Orleans from June 21-24.
In other recent news, GE HealthCare Technologies Inc. reported strong financial results for the first quarter of 2025, with revenue reaching $4.8 billion, marking a 4% organic growth. The company also saw a 12% increase in adjusted earnings per share, reaching $1.01. GE HealthCare announced the issuance of $1.5 billion in senior unsecured notes, comprising $650 million in 4.800% notes due in 2031 and $850 million in 5.500% notes due in 2035. Additionally, GE HealthCare secured stockholder approval for executive compensation, re-elected 10 directors, and ratified Deloitte & Touche LLP as its independent auditor for 2025. The company’s recent annual stockholder meeting also resulted in the rejection of a stockholder proposal concerning termination pay arrangements. Furthermore, GE HealthCare launched several innovative products, including a new PET imaging agent, and achieved a record backlog of $20.6 billion. The company projects organic revenue growth of 2% to 3% for the full year 2025, with an adjusted EBIT margin between 14.2% and 14.4%.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.